Skip to main content
Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma

Fig. 3

Pre-treatment peripheral chemokine levels associated with response and OS. a Baseline (pre-treatment) levels of indicated chemokines according to response status. Each point represents a donor, average is outlined, and error bars represent SEM. ns: not significant; *: p < 0.05 from a one-way ANOVA with Bonferroni post hoc test. b Kaplan-Meier OS curves for the indicated chemokines stratified by levels above (high) or below (low) the mean level for each chemokine. P values were calculated using the log-rank test and are shown on each graph

Back to article page